Penny's BreakOuts

[Pennyes]

TSOI & Sunshine BioPharma, Today's Breakouts!!

TSOI, as a Dietary supplement, the trials does not require Phase0-Phase 4, but direct approval after the initial trials that are ongoing with 500 Patients. The FDA approval or green signal to TSOIs is highly likely because of the type of molecules that is naturally derived (supplemented?), as the stock already followed through FIB Retracement, look for fireworks beginning today, but tomorrow and moving forward, the Breakout resumes and goes further up, did you see what is happening with Sunshine, expect similar or much better moves here too!!. Enjoy the ride!!
==========================

ClinicalTrials.gov Identifier: NCT04421391
Recruitment Status : Recruiting
First Posted : June 9, 2020
Last Update Posted : June 9, 2020

Condition or disease Intervention/treatment Phase
Covid19 Coronavirus SARS-CoV 2
Dietary Supplement: QuadraMune(TM) Not Applicable


The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4.
Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.

https://clinicaltrials.gov/ct2/show/NCT04421391